InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by McClurg Ronald W., Chief Financial Officer. Insider active across 1 company, notably NEUROONE MEDICAL TECHNOLOGIES Corp. In total, 5 filings have been logged. Split: 3 buys · 0 sell. Total volume traded: €38k. Activity tracked since 3 February 2022. The latest transaction was disclosed on 15 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
10,000 shares@ US$1.02190.022% mcap25.9% of flowCommon StockSEC:0001837830-22-000004:0
Ideal exit: 12 Mar 2023 (T+270)
14,000 shares@ US$1.05580.031% mcap36.8% of flowCommon StockSEC:0001837830-22-000003:0
Ideal exit: 7 Mar 2023 (T+270)
17,500 shares@ US$0.85280.032% mcap37.3% of flowCommon StockSEC:0001837830-22-000002:0
Ideal exit: 14 Feb 2023 (T+270)
15,000 shares0Common StockSEC:0001837830-22-000001
15,000 shares0Common StockSEC:0001837830-22-000001:0
5 of 5 declarations
About McClurg Ronald W.
Ronald W. McClurg is the Chief Financial Officer of NeuroOne Medical Technologies Corp. He is responsible for the company's financial management, including budgeting and risk management. With a strong background in finance, he plays a key role in the financial strategy and performance of the company.
